Patents Assigned to Johnson & Johnson Innovation LLC
  • Patent number: 9597441
    Abstract: The general disclosure discusses a system and method for improving the efficacy of blood filtration treatments such as hemodialysis, hemofiltration, and hemodiafiltration. More particularly, the disclosure discusses a microfluidic device that includes first and second channels separated by a permeable membrane. One of the channels is configured for blood flow and includes a protein gel disruption layer. The protein gel disruption layer includes a plurality of elements at least partially extending across the blood flow channel that reduce the formation of a boundary layer or gel layer at the blood-membrane interface.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: March 21, 2017
    Assignee: Johnson & Johnson Innovation LLC
    Inventors: Jeffrey T. Borenstein, Joseph L. Charest, Chris DiBiasio, Violet Finley